The new genetics and informed consent: differentiating choice to preserve autonomy

Area of Science:

• Bioethics
• Genomic Medicine
• Informed Consent

Background:

• Advanced genetic and genomic technologies, including whole-genome sequencing, enable simultaneous testing for numerous genetic abnormalities and predispositions.
• These capabilities challenge traditional notions of informed consent due to the complexity and scope of information involved.
• Ethical considerations arise in applying these technologies to newborn screening, prenatal diagnostics, and commercial personal genome testing.

Purpose of the Study:

• To re-evaluate the ethical framework for genetic testing and screening in light of new genomic technologies.
• To explore the implications of these technologies for the principle of respect for autonomy, particularly for future generations.
• To propose new approaches for informed consent processes in genetic testing.

Main Methods:

• Analysis of ethical challenges presented at the 11th World Congress of Bioethics.
• Building upon existing ethical frameworks for genetic testing and screening.
• Reinterpretation of ethical criteria in the context of 'new genetics'.

Main Results:

• The scope of genetic testing offers must align with testing purposes and respect the autonomy of all stakeholders, including children.
• Current informed consent models require adaptation to accommodate the complexities of genomic data.
• Individualized or differentiated approaches to testing offers and consent processes are necessary.

Conclusions:

• A revised understanding of informed consent is essential for the responsible implementation of new genetic technologies.
• Ethical guidelines must evolve to ensure respect for autonomy in genomic healthcare and direct-to-consumer services.
• Developing new strategies for informed consent is critical for navigating the ethical landscape of modern genetics.